The Role of Ultrasound in Endometrial Cancer
Journal Title: International Journal of Clinical Therapeutics and Diagnosis (IJCTD) - Year 2015, Vol 0, Issue 1
Abstract
Endometrial cancer is the most common gynecologic malignancy in developed countries. The vast majority of cases occur after menopause, with postmenopausal bleeding being the presenting symptom in 95% of the cases. The use of transvaginal ultrasonography (TVS) is the sin e qua non in the assessment of these women. The finding of endometrial thickness of 5 mm or more is associated with increased likelihood for endometrial cancer, and should prompt further investigations. In cases with confirmed endometrial cancer, MRI and ultrasound are used to assess the depth of invasion to the myometrium and the cervical stroma. Recent studies have shown that – in experienced hands - a combination of gray-scale ultrasound with color and/or power Doppler examination has comparable results to that of MRI in the estimation of cancer invasion ≥ 50% in the myometrium or in the cervical stroma. Lack of uniformity in objective measurements is the main problem that hampers our ability to correctly predict myometrial or cervical stroma invasion with ultrasound. However, ultrasound is cheap, easy to perform and more readily available than any other imaging modality. The present article examines the use of gray-scale and Doppler ultrasound imaging in estimating the risk of endometrial cancer.
Authors and Affiliations
V. Papadopoulos
Keywords
Related Articles
- EP ID EP202995
- DOI 10.19070/2332-2926-SI01001
- Views 141
- Downloads 0
Autophagy: a potential therapeutic target in cardiac lipotoxicity?
Autophagy: a potential therapeutic target in cardiac lipotoxicity?
Now Moments in Professional Care - The Importance of Positive Affect in Patient-Therapist Matching
Regarding clinical work, it is known that especially the positive affect shown to the patient and the continuous unwavering interest in the patient are the main criteria for a successful treatment and treatment planning....
ErbB Targeted Therapy in Endometrial Cancer
The potential role of ErbB receptors (especially EGFR and ErbB-2) as targets for cancer therapy has been investigated for over 30 years. Anti-ErbB monoclonal antibodies (MoAbs) bind to the extracellular domain of EGFR or...
Current Treatment Approach of Endometrial Cancer
Systematic surgical staging is the primary treatment, for most patients with endometrial cancer and includes: total hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy and complete resec...
The Role of Ultrasound in Endometrial Cancer
Endometrial cancer is the most common gynecologic malignancy in developed countries. The vast majority of cases occur after menopause, with postmenopausal bleeding being the presenting symptom in 95% of the cases. The us...